Funny thing is, vax rabbit. Vaxxing in the midst of a pandemic CREATES variants. You should bone up on the science before you pop off at the mouth.
Start with Darwin and 'survival of the fittest' and go from there.
#ScienceDenier
Posted on 09/23/2021 10:00:20 PM PDT by ransomnote
Canadian info:
Myocarditis is inflammation of the heart muscle and pericarditis is inflammation of the lining around the heart.
Up to and including September 10, 2021, there were 718 confirmed reports of myocarditis/pericarditis that met Level 1 to 4 of Brighton Collaboration level of diagnostic certainty. Of the myocarditis/pericarditis reports:
408 reports followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, 290 followed vaccination with a Moderna Spikevax COVID-19 vaccine, 18 followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, and the vaccine name of two were unspecified
Among the 408 reports of myocarditis/pericarditis following Pfizer-BioNTech Comirnaty COVID-19 vaccine (administered to those 12 years of age and older):
Symptoms started between 5 minutes and 94 days after vaccination
Median age is 29 years (age range 12 to 87 years old)
258 were males [median age 23 years (age range 12 to 82 years old)], 146 were females [median age 39 years (age range 12 to 87 years old)], and the sex of four were unspecified
176 reports following the first vaccine dose, 183 reports following the second vaccine dose, and the dose number for 49 were not specified
Current analyses show the number of reports of myocarditis/pericarditis following the Pfizer-BioNTech Comirnaty COVID-19 vaccine is higher than what would be expected in the general population of males and females less than 30 years old and following the second dose.
Among the 290 reports of myocarditis following vaccination with a Moderna Spikevax COVID-19 vaccine (administered to those 12 years of age and older):
Symptoms started between 14 minutes and 69 days after vaccination
Median age is 28 years (age range 18 to 95 years old)
211 were males [median age 26 years (age range 18 to 95 years old)], 75 were females [median age 35 years (age range 18 to 76)], the sex of one was ‘other’, and the sex of three were unspecified
59 reports following the first vaccine dose, 199 reports following the second vaccine dose, and the dose number for 32 were unspecified
Current analyses show the number of reports of myocarditis/pericarditis following the Moderna Spikevax COVID-19 vaccine is higher than what would be expected in the general population, particulary among males and females less than 40 years old and following the second dose.
Evidence is evolving and investigations into the association between myocarditis/pericarditis and mRNA vaccines continue.
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
Also from Canada:
Up to and including September 10, 2021, there are a total of 76 reports of GBS that met Level 1 to 4 of Brighton Collaboration level diagnostic certainty.. Of the GBS reports:
30 reports followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, 31 followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, and 15 followed vaccination with a Moderna Spikevax COVID-19 vaccine.
Current results show the rate of GBS following AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccination is higher than the rate of GBS following Pfizer-BioNTech Comirnaty COVID-19 vaccine or Moderna Spikevax COVID-19 vaccine. As well, the number of reports of GBS following AstraZeneca Vaxzevria/COVISHIELD vaccination are higher than would normally be expected in the general population.
Among the 30 reports of GBS following an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine:
Symptoms started between 6 hours and 25 days after vaccination
Median age is 55 years (age range 40 to 77 years old)
22 were males [median age 55 years (age range 40 to 66 years old)], 7 were females [median age 51 years (age range 40 to 77 years old)], and the age and sex of one was unspecified
21 reports following the first vaccine dose, and the dose number for 9 were unspecified
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
Thrombosis with thrombocytopenia syndrome (TTS) is characterized as blood clotting with low platelet levels.
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), also known as Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT), is characterized as TTS that seems to be vaccine-induced due to the laboratory-confirmed presence of platelet factor (PF) 4 antibodies.
Up to and including September 10, 2021, there were 81 reports of TTS that met Level 1 to 4 of Brighton Collaboration level of diagnostic certainty. Of the TTS reports:
61 reports followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, 16 followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, and four followed vaccination with a Moderna Spikevax COVID-19 vaccine.
Of the 61 TTS reports following a AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine:
Symptoms started between 1 and 37 days after vaccination.
Median age is 57 years (age range 19 to 88 years old)
32 were males [median age 57 years (age range 34 to 73 years old)], 28 were females [median age 56 years (age range 19 to 88 years old)], and the age and sex of one was not specified.
55 reports following the first vaccine dose, and the dose number for six were not specified
38 had laboratory results showing the presence of platelet factor (PF) 4 antibodies, indicating VITT (also known as VIPIT).
Six people died.
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
What this doctor is going through after the shot isn’t a walk through the park.
“My entire face felt like it was burning — like acid had been poured on my face. I had sensations throughout my body like it was vibrating. I felt like I had a tight band around my waist, chest pain and shortness of breath, and I went to bed for seven days.”
Canada has about 38 million people and is about 70% vaccinated against Covid.
Pfizer ~43 million doses distributed
Moderna ~18 million doses distributed
AstraZeneca ~3 million doses distributed
“Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Pfizer-BioNTech COVID-19 Vaccine”
“Reports of lymphadenopathy were imbalanced with 58 more cases in the vaccine group (64) than the placebo group (6); lymphadenopathy is plausibly related to the vaccine. Lymphadenopathy occurred in the arm and neck region and was reported within 2 to 4 days after vaccination. The average duration of lymphadenopathy was approximately 10 days. Bell’s palsy was reported by four vaccine recipients and none of the placebo recipients.”
“The most common serious adverse events in the vaccine group which were numerically higher than in the placebo group were appendicitis (7 in vaccine vs 2 in placebo), acute myocardial infarction (3 vs 0), and cerebrovascular accident (3 vs 1).”
https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html
Those comments I believe are for less than 2000 patients.
Severe redness(>10cm) in 3 out of 1802 55+ patients.
“The Moderna COVID-19 Vaccine’s Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events”
“Reports of lymphadenopathy were imbalanced with 1.1 % of persons in the vaccine group and 0.6% in the placebo group reporting such events; lymphadenopathy is plausibly related to the vaccine. Lymphadenopathy occurred in the arm and neck region and was reported within 2 to 4 days after vaccination. The median duration of lymphadenopathy was 1 to 2 days. Bell’s palsy was reported by three vaccine recipients and one placebo recipient. One case of Bell’s palsy in the vaccine group was considered a serious adverse event.”
“The most common serious adverse events occurring at higher rates in the vaccine group than the placebo group were myocardial infarction (5 cases in vaccine group vs. 3 cases in placebo group), cholecystitis (3 vs. 0), and nephrolithiasis (3 vs. 0).”
https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html
Those comments I believe are for less than 3800 patients.
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
Recruiting
Sinai Hospital
Baltimore, Maryland, United States, 21215
https://clinicaltrials.gov/ct2/show/NCT04910971
COVID-19 Vaccines Safety Tracking (CoVaST)
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.
Not yet recruiting
American College of Physicians
Philadelphia, Pennsylvania, United States, 19106
NCT04834869
Thnx for posting. Having a relation here in the UK who suffered Lymphadenopathy after the vaccine, I did some searching myself on investigations. I found this report very informative:
https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EDFDC7E23E32A7246679127CDC16F441/S0022215121002462a.pdf/cervical-lymphadenopathy-following-coronavirus-disease-2019-vaccine-clinical-characteristics-and-implications-for-head-and-neck-cancer-services.pdf
It seems different vaccines have a significantly different incidence; between 50-60% fully resolved (the rest only partially) during the study period.
Makes no sense at all - new 1/3 dose shot for children up to age 11 and then at age 12 it’s a full dose. ?
And as far as I know, Pfizer and the CDC still aren’t lengthening the amount of time between the 1st & 2nd shots. More and more Dr’s are recommending waiting a few months between shots for better efficacy and fewer adverse effects.
Obviously you get paid by the post.
Nice side gig eh?
I know of two people personally who died from the jab.
And do not know of any who “died” from da covid. Of course, it is 99.9% survivable.
Talk to me in three years regarding your advocacy.
bkmk
Wow!
Now we are quoting the NY Times as an authoritative source?
“Vax” pimp’s gotta pimp.
They have no shame.
Heh heh - “It may kill you even when the bug would be handled easily - but it’s your duty to risk the jab and become part of the data set as we discover all the problems over the next 5-10 years...”
Funny thing is, vax rabbit. Vaxxing in the midst of a pandemic CREATES variants. You should bone up on the science before you pop off at the mouth.
Start with Darwin and 'survival of the fittest' and go from there.
#ScienceDenier
Any possibility this person also went by 2amendmentprotectstherest.
could be...
I had the same thought
Thanks for posting this. Eventually, this stuff must reach a critical mass among those few remaining people in government with any sort of conscience.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.